Differential response of estrogen receptors α and β to SP500263, a novel potent selective estrogen receptor modulator

Molecular Pharmacology

Volumn 61, Issue 3, 2002, Pages 562-568

  Brady, Helen ^a   Doubleday, Mary ^a   Gayo Fung, Leah M ^a   Hickman, Matt ^a   Khammungkhune, Sak ^a   Kois, Adam ^a   Lipps, Stephanie ^a   Pierce, Steve ^a   Richard, Normand ^a   Shevlin, Graciella ^a   Sutherland, May Kung ^a   Anderson, David W ^a   Bhagwat, Shripad S ^a   Stein, Bernd ^a  

^a CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXY 3 PHENYL 4 [4 (2 PIPERIDINOETHOXY)BENZYL] 2H CHROMEN 2 ONE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INTERLEUKIN 6; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CELL PROLIFERATION; ESTROGEN RESPONSIVE ELEMENT; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIGAND BINDING; OSTEOPOROSIS; OSTEOSARCOMA CELL; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

CELLS, CULTURED; COUMARINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-6; PIPERIDINES; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; TUMOR CELLS, CULTURED;

EID: 18244401387     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.61.3.562     Document Type: Article

References (41)

1. Interleukin 6 is required for the development of collagen-induced arthritis
2. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists
3. Effects of SP500263, a novel, potent antiestrogen on breast cancer cells and in xenograft models
4. 50) of an enzymatic reaction
5. Characterization of the role of IL-6 in the progression of prostate cancer
6. Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro
7. Involvement of CCAAT/enhancer-binding protein and nuclear factor-κB binding sites in interleukin-6 promoter inhibition by estrogens
8. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κB site
9. 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens
10. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering
11. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A
12. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo
13. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor
14. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
15. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptor
16. Molecular and cellular biology of interleukin-6 and its receptor
17. Interleukin-6 family of cytokines and gp130
18. Impaired immune and acute-phase responses in interleukin-6-deficient mice
19. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
20. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor
21. Steroid receptors in human breast cancer
22. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo
23. Estrogen receptor subtype-selective ligands: Asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl-5,6,11,12-tetrahydrochrysenes
24. Anticytokine therapy in autoimmune diseases
25. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
26. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal
27. Differential activation by xenoestrogens of ER alpha and ER beta when linked to different response elements
28. IL-6 unique functions in inflammation, bone metabolism, and B-cell neoplasias revealed by studies on IL-6 deficient mice
29. Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor
30. Repression of interleukin-6 gene expression by 17β-estradiol: Inhibition of the DNA binding activity of the transcription factors NF-IL6 and NF-κB by the estrogen receptor
31. Effect of interleukin-6 secreted by engineered human stromal cells on osteoclasts in human bone
32. Interleukin-6-type cytokines
33. IL-6 as a drug discovery target
34. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ
35. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen recepter-beta
36. Age-dependent expression of osteoblastic phenotypic markers in normal human osteoblasts cultured long-term in the presence of dexamethasone
37. QSAR models for binding of estrogenic compounds to estrogen receptor α and β subtypes
38. Interleukin-6 in renal cell carcinoma
39. Interleukin-6: An overview
40. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: Functional difference between estrogen receptors α and β
41. The role of interleukin-6 in the induction of hypercalcemia in renal cell carcinoma transplanted into nude mice